TCM Product listing in Singapore is a regulatory service to support Chinese Proprietary Medicine manufacturers to list their product with the local regulatory authority in Singapore: HSA.

The scope of work will cover the following:
-Assessment and review of documents to ensure compliance to local regulations
– Compilation of documents for submission
– Submission of CPM listing on PRISM
-Liaison support between Client and authority throughout the listing process is announced

*Note: A monthly charge will apply being the  licence holder for the TCM which will be charged once approval is obtained.

中医药产品上市服务（新加坡）是一项为中成药制造商提供的法规服务，旨在帮助其将产品在新加坡本地监管机构——新加坡卫生科学局 (HSA) 上市。

服务范围包括：

• 评估和审核文件，确保符合本地法规要求
• 编制文件以便提交
• 在PRISM系统上提交中成药的上市申请
• 在整个上市过程中提供端到端的法规提交支持

*注意：作为中医药产品的持证人，获得批准后将收取每月费用。